PTH and pachyonychia congenita: Future work should be extended to develop a recurrence stratification system that incorporates clinical factors, biochemical parameters (PTH, calcium level), pathological evidence (microscopic and macroscopic invasion), genetic defects (mutations and/or loss of the CDC73 tumor suppressor gene, which has been recognized to be the main genetic defects of PC) and other anatomical factors.